Estradiol (Oestrogel® Pump Gel). HTA ID: 20013

Assessment Status Rapid review complete
HTA ID 20013
Drug Estradiol
Brand Oestrogel® Pump Gel
Indication For: Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women; Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.
Assessment Process
Rapid review commissioned 09/03/2020
Rapid review completed 09/04/2020
Rapid review outcome A full HTA is not recommended. The NCPE recommends that Oestrogel® pump be considered for reimbursement*.

*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013

The HSE has approved reimbursement; August 2020.